Left ventricular diastolic dysfunction is associated with impaired baroreflex at rest and during orthostatic stress in hypertensive patients with left ventricular hypertrophy

Journal of Human Hypertension

Volumn 27, Issue 8, 2013, Pages 465-473

  Makowski, K ^a   Gielerak, G ^a   Kramarz, E ^a   Wierzchon S ^b   Kaminski G ^a   Kowal, J ^a   Krzesinski P ^a   Zegadlo A ^a   Skrobowski, A ^a  

^a MILITARY INSTITUTE OF MEDICINE   (Poland)

^b INSTITUTE OF COMPUTER SCIENCE   (Poland)

Author keywords

Baroreflex sensitivity; Head up tilt test; Left ventricular diastolic function; Left ventricular hypertrophy; Pharmacotherapy

Indexed keywords

AMLODIPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HYDROCHLOROTHIAZIDE; TELMISARTAN;

ADD ON THERAPY; ADULT; ARTICLE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR RESPONSE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEALTH STATUS; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CONTRACTILE FORCE; HEART MUSCLE RELAXATION; HEART VENTRICLE FILLING; HUMAN; HYPERTENSION; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; LONG TERM CARE; MALE; ORTHOSTATIC STRESS; PRESSORECEPTOR REFLEX; REENTRY TACHYCARDIA; REST; SINUS TACHYCARDIA; SUPINE POSITION; TILTING; TRANSTHORACIC ECHOCARDIOGRAPHY;

BAROREFLEX; BLOOD PRESSURE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; POSTURE; PROSPECTIVE STUDIES; STRESS, PHYSIOLOGICAL; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84880321064     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2013.10     Document Type: Article

References (35)

1. Paulus WJ, Tschope C, Sanderson JE, Rusconi C, Flachskampf FA, Rademakers FE et al. How to diagnose diastolic heart failure: A consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 2007; 28: 2539-2550
2. Laitinen T, Niskanen L, Geelen G, Lansimies E, Hartikainen J. Age dependency of cardiovascular autonomic responses to head-up tilt in healthy subjects. J Appl Physiol 2004; 96: 2333-2340
3. Makowski K, Gielerak G, Cholewa M, Kramarz E, Michalkiewicz D, Kamiń ski G et al. Autonomic nervous system and left ventricular hypertrophy in essential hypertension. Kardiol Pol 2002; 57: 520-531
4. Radaelli A, Bernardi L, Valle F, Leuzzi S, Salvucci F, Pedrotti L et al. Cardiovascular autonomic modulation in essential hypertension. Effect of tilting. Hypertension 1994; 24: 556-563
5. Giannattasio C, Cattaneo BM, Seravalle G, Grassi G, Mancia G. Left ventricular hypertrophy and the cardiogenic reflex in man. J Hypertens 1991; 9: 43-50
6. Muller-Brunotte R, Kahan T, Malmqvist K, Ring M, Edner M. Tissue velocity echocardiography shows early improvement in diastolic function with irbesartan and atenolol therapy in patients with hypertensive left ventricular hypertrophy. Results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA). Am J Hypertens 2006; 19: 927-936
7. Devereux RB, Wachtel K, Gerdts E, Boman K, Nieminen MS, Papademetriou V et al. Prognostic significance of left ventricular mass change during treatment of hypertension. JAMA 2004; 292: 2350-2356
8. Kane GC, Karon BL, Mahoney DW, Redfield MM, Roger VL, Burnett Jr JC et al. Progression of left ventricular diastolic dysfunction and risk of heart failure. JAMA 2011; 306: 856-863
9. Fagard R, Pardaens K. Left ventricular diastolic function predicts outcome in uncomplicated hypertension. Am J Hypertens 2001; 14: 504-508
10. Wang M, Yip GWK, Wang AYM, Zhang Y, Ho PY, Tse MK et al. Tissue Doppler imaging provides incremental prognostic value in patients with systemic hypertension and left ventricular hypertrophy. J Hypertens 2005; 23: 183-191
11. Lantelme P, Khettab F, Custaud MA, Rial MO, Joanny C, Gharib C et al. Sontaneous baroreflex sensitivity: Toward an ideal index of cardiovascular risk in hypertension? J Hypertens 2002; 20: 935-944
12. Ormezzano O, Cracowski JL, Quesada JL, Pierre H, Mallion JM, Baguet JP. Evaluation of the prognostic value of BARoreflex sensitivity in hypertensive patients: The EVABAR study. J Hypertens 2008; 26: 1373-1378
13. Grassi G, Seravalle G, Quarti-Trevano F, Dell'Oro R, Arenare F, Spaziani D et al. Sympathetic and baroreflex cardiovascular control in hypertension-related left ventricular dysfunction. Hypertension 2009; 53: 205-209
14. Milan A, Caserta MA, Del Colle S, Dematteis A, Morello F, Rabbia F et al. Baroreflex sensitivity correlates with left ventricular morphology and diastolic function in essential hypertension. J Hypertens 2007; 25: 1655-1664
15. Mancia G, de Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G et al. 2007 Guidelines for the management of arterial hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25: 1105-1187
16. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977; 55(4): 613-618
17. Hammond IW, Devereux RB, Alderman MH, Lutas EM, Spitzer MC, Crowley JS et al. The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension. J Am Coll Cardiol 1986; 7: 639-650
18. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA et al. Recommendations for chamber quantification: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18: 1440-1463
19. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 2009; 22: 107-133
20. Parati G, Di Rienzo M, Bertinieri G, Pomidossi G, Casadei R, Groppelli A et al. Evaluation of the baroreceptor-heart rate reflex by 24-h intra-arterial blood pressure monitoring in humans. Hypertension 1988; 12: 214-222
21. Gerritsen J, TenVoorde BJ, Dekker JM, Kostense PJ, Bouter LM, Heethaar RM. Baroreflex sensitivity in the elderly: Influence of age, breathing, and spectral methods. Clin Sci (Colch) 2000; 99: 371-381
22. Hastie T, Tibshirani R, Friedman J. MARS: Multivariate adaptive regression splines. In: Hastie T, Tibshirani R, Friedman J (eds). The Elements of Statistical Learning: Data Mining, Inference, and Prediction. Springer: New York, NY, 2nd edn, 2009, pp 321-329
23. Mostarda C, Moraes-Silva IC, Moreira ED, Medeiros A, Piratello AC, Consolim- Colombo FM et al. Baroreflex sensitivity impairment is associated with cardiac diastolic dysfunction in rats. J Cardiac Fail 2011; 17: 519-525
24. Schlaich MP, Sobotka PA, Krum H, Lambert EA, Esler MD. Renal sympathetic nerve ablation for the treatment of uncontrolled hypertension. N Engl J Med 2009; 361: 932-934
25. Heusser K, Tank J, Engeli S, Diedrich A, Menne J, Eckert S et al. Carotid baroreceptor stimulation, sympathetic activity, baroreflex function, and blood pressure in hypertensive patients. Hypertension 2010; 55: 619-626
26. Bisognano JD, Kaufman CL, Bach DS, Lovett EG, de Leeuw P. DEBuT-HT and Rheos Feasibility Trial Investigators. Improved cardiac structure and function with chronic treatment using an implantable device in resistant hypertension: Results from European and United States trials of the Rheos system. J Am Coll Cardiol 2011; 57: 1787-1788
27. Brandt MC, Mahfoud F, Reda S, Schirmer SH, Erdmann E, Bohm M et al. Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension. J Am Coll Cardiol 2012; 59: 901-909
28. Wang W, Schultz HD, Ma R. Cardiac sympathetic afferent sensitivity is enhanced in heart failure. Am J Physiol 1999; 277: H812-H817
29. Gao L, Schultz HD, Patel KP, Zucker IH, Wang W. Augmented input from cardiac sympathetic afferents inhibits baroreflex in rats with heart failure. Hypertension 2005; 45: 1173-1181
30. Levick SP, Murray DB, Janicki JS, Brower GL. Sympathetic nervous system modulation of inflammation and remodeling in the hypertensive heart. Hypertension 2010; 55: 270-276
31. Barbieri R, Triedman JK, Saul P. Heart rate control and mechanical cardiopulmonary coupling to assess central volume: A systems analysis. Am J Physiol Regul Integr Comp Physiol 2002; 283: 1210-R1220
32. Iwasaki K, Zhang R, Perhonen MA, Zuckerman JH, Levine BD. Reduced baroreflex control of heart period after bed rest is normalized by acute plasma volume restoration. Am J Physiol Regul Integr Comp Physiol 2004; 287: 1256-1262
33. Pagani M, Montano N, Porta A, Malliani A, Abboud FM, Birkett C et al. Relationship between spectral components of cardiovascular variabilities and direct measures of muscle sympathetic nerve activity in humans. Circulation 1997; 95: 1441-1448
34. Charkoudian N, Joyner MJ, Johnson C, Eisenach J, Dietz N, Wallin BG. Balance between cardiac output and sympathetic nerve activity in resting humans: Role in arterial pressure regulation. J Physiol 2005; 568: 315-321
35. Dokainish H, Nguyen JS, Sengupta R, Pillai M, Alam M, Bobek J et al. Do additional echocardiographic variables increase the accuracy of E/e' for predicting left ventricular filling pressure in normal ejection fraction? An echocardiographic and invasive hemodynamic study. J Am Soc Echocardiogr 2010; 23: 156-161